![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 19
Zeitschriftenartikel
Boukovala, Myrto; Modest, Dominik Paul; Ricard, Ingrid; Fischer von Weikersthal, Ludwig; Decker, Thomas; Vehling-Kaiser, Ursula; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Peveling Genannt Reddemann, C.; Graeven, Ullrich 
ORCID: https://orcid.org/0000-0001-6082-7710; Schuch, Gunter ORCID: https://orcid.org/0000-0001-7503-457X; Schwaner, Ingo ORCID: https://orcid.org/0000-0001-8865-7282; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Neumann, Jens; Jung, Andreas; Held, Swantje ORCID: https://orcid.org/0000-0002-1344-9056; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321 und Michl, Marlies ORCID: https://orcid.org/0000-0002-4198-3627
(2024):
Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110).
In: ESMO Open, Bd. 9, Nr. 5, 103374
[PDF, 725kB]
ORCID: https://orcid.org/0000-0001-6082-7710; Schuch, Gunter ORCID: https://orcid.org/0000-0001-7503-457X; Schwaner, Ingo ORCID: https://orcid.org/0000-0001-8865-7282; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Neumann, Jens; Jung, Andreas; Held, Swantje ORCID: https://orcid.org/0000-0002-1344-9056; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321 und Michl, Marlies ORCID: https://orcid.org/0000-0002-4198-3627
(2024):
Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110).
In: ESMO Open, Bd. 9, Nr. 5, 103374
[PDF, 725kB]
Seckin, Mustafa; Ricard, Ingrid; Raiser, Theresa; Heitkamp, Nari; Ebert, Anne; Prix, Catharina; Levin, Johannes; Diehl-Schmid, Janine; Riedl, Lina; Rossmeier, Carola; Hoen, Nora; Schroeter, Matthias L.; Marschhauser, Anke; Obrig, Hellmuth; Benke, Thomas; Kornhuber, Johannes; Fliessbach, Klaus; Schneider, Anja; Wiltfang, Jens; Jahn, Holger; Fassbender, Klaus; Prudlo, Johannes; Lauer, Martin; Duning, Thomas; Wilke, Carlo; Synofzik, Matthis; Anderl-Straub, Sarah; Semler, Elisa; Lombardi, Jolina; Landwehrmeyer, Bernard; Ludolph, Albert; Otto, Markus und Danek, Adrian
(2022):
Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive Aphasia.
In: Alzheimer Disease and Associated Disorders, Bd. 36, Nr. 1: S. 44-51
Liu, Lian; Erickson, Nicole Tonya; Ricard, Ingrid; Weikersthal, Ludwig Fischer von; Lerch, Markus M.; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Hoeffkes, Heinz-Gert; Moehler, Markus; Gesenhues, Alena Britta; Theurich, Sebastian; Michl, Marlies; Modest, Dominik P.; Alguel, Hana; Stintzing, Sebastian; Heinemann, Volker und Holch, Julian W.
(2021):
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
In: International Journal of Cancer, Bd. 150, Nr. 1: S. 112-123
Heinrich, Kathrin; Modest, Dominik P.; Ricard, Ingrid; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Graeven, Ullrich; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Giessen-Jung, Clemens; Stahler, Arndt; Michl, Marlies; Held, Swantje; Jung, Andreas; Kirchner, Thomas; Stintzing, Sebastian und Heinemann, Volker
(2021):
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110).
In: European Journal of Cancer, Bd. 147: S. 128-139
Modest, Dominik Paul; Heinemann, Volker; Folprecht, Gunnar; Denecke, Timm; Pratschke, Johann; Lang, Hauke; Bemelmans, Marc; Becker, Thomas; Rentsch, Markus; Seehofer, Daniel; Bruns, Christiane J.; Gebauer, Bernhard; Held, Swantje; Stahler, Arndt; Heinrich, Kathrin; Einem, Jobst C. von; Stintzing, Sebastian; Neumann, Ulf P. und Ricard, Ingrid
(2020):
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3-AIOKRK0306.
In: Annals of Surgical Oncology, Bd. 27, Nr. 7: S. 2389-2401
Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik P.; Ricard, Ingrid; Giessen-Jung, Clemens; Kapaun, Christine; Ivanova, Boryana; Kaiser, Florian; Fischer von Weikersthal, Ludwig; Moosmann, Nicolas; Schalhorn, Andreas; Stauch, Martina; Kiani, Alexander; Held, Swantje; Decker, Thomas; Moehler, Markus; Neumann, Jens; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker
(2020):
Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials.
In: Clinical Cancer Research, Bd. 26, Nr. 24: S. 6559-6567
Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Heinemann, Volker; Ricard, Ingrid; Einem, Jobst C. von; Giessen-Jung, Clemens; Westphalen, Christoph Benedikt; Michl, Marlies; Heinrich, Kathrin; Miller-Phillips, Lisa; Jelas, Ivan; Stintzing, Sebastian und Modest, Dominik Paul
(2020):
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials.
In: Journal of cancer research and clinical oncology, Bd. 146, Nr. 8: S. 2077-2087
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-1041-0137; Heinemann, Volker; Ricard, Ingrid; Einem, Jobst C. von; Giessen-Jung, Clemens; Westphalen, Christoph Benedikt; Michl, Marlies; Heinrich, Kathrin; Miller-Phillips, Lisa; Jelas, Ivan; Stintzing, Sebastian und Modest, Dominik Paul
(2020):
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials.
In: Journal of cancer research and clinical oncology, Bd. 146, Nr. 8: S. 2077-2087
[PDF, 1MB]
Vöglein, Jonathan; Ricard, Ingrid; Noachtar, Soheyl; Kukull, Walter A.; Dieterich, Marianne; Levin, Johannes und Danek, Adrian
(2020):
Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course.
In: Journal of neurology, Bd. 267: S. 2941-2948
[PDF, 839kB]
Stintzing, Sebastian; Ivanova, Boryana; Ricard, Ingrid; Jung, Andreas; Kirchner, Thomas; Tannapfel, Andrea; Juette, Hendrik; Hegewisch-Becker, Susanna; Arnold, Dirk und Reinacher-Schick, Anke
(2018):
Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial.
In: Frontiers in Oncology, Bd. 8, Nr. 474
[PDF, 1MB]
Hofmann, Felix O.; Holch, Julian W.; Heinemann, Volker; Ricard, Ingrid; Reiser, Maximilian F.; Baumann, Alena B.; Hesse, Nina; D'Anastasi, Melvin; Modest, Dominik P.; Stintzing, Sebastian und Sommer, Wieland H.
(2018):
Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial.
In: European Journal of Radiology, Bd. 100: S. 124-129
Modest, Dominik P.; Denecke, Timm; Pratschke, J.; Ricard, Ingrid; Lang, H.; Bemelmans, M.; Becker, T.; Rentsch, Markus; Seehofer, Daniel; Bruns, Christiane J.; Gebauer, B.; Modest, H. I.; Held, S.; Folprecht, Gunnar; Heinemann, Volker und Neumann, Ulf Peter
(2018):
Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3.
In: European Journal of Cancer (EJC), Bd. 88: S. 77-86
Holch, Julian W.; Ricard, Ingrid; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Scholz, Michael; Müller, Sebastian; Link, Hartmut; Rost, Andreas; Höffkes, Heinz-Gert; Moehler, Markus; Lindig, Reinhard Udo; Miller-Phillips, Lisa; Kirchner, Thomas; Jung, Andreas; Einem, Jobst C. von; Modest, Dominik Paul und Heinemann, Volker
(2018):
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
In: International Journal of Cancer, Bd. 142, Nr. 5: S. 1047-1055
Jochheim, David; Zadrozny, M.; Ricard, Ingrid; Sadry, T. M.; Theiss, H.; Baquet, Moritz; Schwarz, F.; Bauer, Axel; Khandoga, A.; Sadoni, S.; Pichlmaier, M.; Hausleiter, J.; Hagl, C.; Massberg, Steffen und Mehilli, Julinda
(Oktober 2017):
Predictors of cerebrovascular events at mid-term after transcatheter aortic valve implantation - results from EVERY-TAVI registry.
In: International Journal of Cardiology, Bd. 244: S. 106-111
Holch, Julian W.; Ricard, Ingrid; Stintzing, Sebastian; Modest, Dominik P. und Heinemann, Volker
(Januar 2017):
The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials.
In: European Journal of Cancer, Bd. 70: S. 87-98
Modest, Dominik P.; Denecke, Timm; Pratschke, J.; Ricard, Ingrid; Lang, H.; Bemelmans, M.; Becker, T.; Rentsch, M.; Seehofer, D.; Bruns, C. J.; Gebauer, B.; Modest, H. I.; Held, S.; Folprecht, Gunnar; Heinemann, Volker und Neumann, Ulf Peter
(2017):
Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3.
In: European Journal of Cancer, Bd. 88: S. 77-86
Modest, Dominik P.; Ricard, Ingrid; Stintzing, Sebastian; Fischer von Weikersthal, L.; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S.-E.; Heintges, T.; Kahl, C.; Seipelt, G.; Kullmann, F.; Scheithauer, W.; Moehler, M.; Westphalen, C. B.; Holch, Julian W.; Einem, J. C. von; Held, S. und Heinemann, Volker
(2017):
Evaluation of survival across several treatment lines in
metastatic colorectal cancer: analysis of the FIRE-3 trial (AIO KRK0306).
In: European Journal of Cancer, Bd. 84: S. 262-269
Herbst, Andreas; Vdovin, Nikolay; Gacesa, Sanja; Philipp, Alexander; Nagel, Dorothea; Holdt, Lesca M.; Winkel, Mark op den; Heinemann, Volker; Stieber, Petra; Graeven, Ullrich; Reinacher-Schick, Anke; Arnold, Dirk; Ricard, Ingrid; Mansmann, Ulrich; Hegewisch-Becker, Susanna und Kolligs, Frank T.
(2017):
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
In: International Journal of Cancer, Bd. 140, Nr. 9: S. 2134-2144
Modest, Dominik P.; Ricard, Ingrid; Heinemann, Volker; Hegewisch-Becker, S.; Schmiegel, W.; Porschen, R.; Stintzing, Sebastian; Graeven, U.; Arnold, D.; Fischer von Weikersthal, L.; Giessen-Jung, Clemens; Stahler, A.; Schmoll, H. J.; Jung, A.; Kirchner, T.; Tannapfel, A. und Reinacher-Schick, A.
(September 2016):
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group.
In: Annals of Oncology, Bd. 27, Nr. 9: S. 1746-1753
[PDF, 410kB]
Levin, J.; Maaß, Sylvia; Schuberth, M.; Respondek, G.; Paul, F.; Mansmann, Ulrich; Oertel, W. H.; Lorenzl, S.; Krismer, F.; Seppi, K.; Poewe, W.; Wenning, G.; Berg, D.; Claßen, J.; Ebersbach, G.; Eggert, K.; Kassubek, J.; Lipp, A.; Lohle, M.; Mollenhauer, B.; Munchau, A.; Sudmeyer, M.; Blankenstein, C.; Eberhardt, C.; Ertl-Wagner, Birgit; Heise, H.; Ricard, Ingrid; Giese, A.; Bötzel, K. und Höglinger, G.
(2016):
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
In: Journal of Neural Transmission, Bd. 1232, Nr. 11: S. 1357-1358